TP53 and breast cancer: To test this hypothesis, we ectopically over-expressed miR-766 in a panel of wild-type p53 cancer cell lines derived from breast cancer, lung cancer and sarcoma (Supplementary Figure 2) to observe its effect on p53 levels.